Skip to main content
. 2017 Mar 16;7:44445. doi: 10.1038/srep44445

Table 5. Methylation in FKBP5, grouped based on GC replacement therapy.

Probe Positiona GCRT - yesb GCRT - noc Delta_betad p qvale
cg03546163 35654363 0.484 0.588 −0.104 2.99E-06 1
cg00052684 35694245 0.514 0.550 −0.036 0.00159 1
cg08586216 35612351 0.981 0.976 0.0050 0.0122 1
cg25114611 35696870 0.314 0.339 −0.025 0.0218 1
cg08915438 35697759 0.559 0.588 −0.029 0.0599 1
cg16052510 35603143 0.809 0.783 0.026 0.0995 1
cg20813374 35657180 0.442 0.462 −0.020 0.109 1
cg00130530 35657202 0.690 0.710 −0.020 0.115 1
cg19226017 35697185 0.752 0.770 −0.018 0.137 1
cg10300814 35565116 0.948 0.953 −0.0050 0.175 1
cg06087101 35551932 0.418 0.440 −0.022 0.197 1
cg14642437 35652521 0.876 0.888 −0.012 0.204 1
cg19014730 35635985 0.681 0.695 −0.014 0.226 1
cg07843056 35656848 0.0257 0.0229 0.0028 0.305 1
cg07485685 35696061 0.0394 0.0375 0.0019 0.409 1
cg17085721 35645341 0.945 0.949 −0.004 0.442 1
cg07061368 35631736 0.894 0.901 −0.007 0.485 1
cg17030679 35696300 0.0215 0.0227 −0.0012 0.520 1
cg00610228 35695934 0.0368 0.0359 0.0009 0.582 1
cg16012111 35656758 0.0484 0.0500 −0.0016 0.585 1
cg23416081 35693573 0.208 0.199 0.009 0.613 1
cg11845071 35695859 0.0209 0.0202 0.0007 0.616 1
cg00140191 35656242 0.0634 0.0615 0.0019 0.661 1
cg08636224 35657921 0.961 0.962 −0.001 0.686 1
cg01294490 35656906 0.0934 0.0913 0.0021 0.687 1
cg18726036 35543610 0.946 0.947 −0.001 0.707 1
cg03591753 35659141 0.539 0.534 0.005 0.720 1
cg14284211 35570224 0.139 0.134 0.005 0.738 1
cg06937024 35695489 0.0259 0.0264 −0.0005 0.791 1
cg00862770 35655764 0.0256 0.0251 0.0005 0.795 1
cg02665568 35544468 0.921 0.923 −0.002 0.799 1
cg07633853 35569471 0.155 0.157 −0.002 0.829 1
cg15929276 35687457 0.187 0.186 0.001 0.911 1
cg10913456 35656590 0.0175 0.0175 0.000 0.989 1

Summary of methylation (reported as beta-values) in FKBP5 on chromosome 6. GCRT = glucocorticoid replacement therapy.

aHuman genome build 37.

bPatients receiving GCRT.

cPatients not receiving GCRT.

dDifference in methylation between patients receiving GCRT and those not receiving such therapy.

eq-values from multiple correction analysis using a 10% FDR.